Back to mobile site

Baird Reiterates an 'Outperform' on Amgen (AMGN); Anticipate a Strong Q212

July 16, 2012 7:31 AM EDT Send to a Friend
Baird reiterates an 'Outperform' on Amgen (NASDAQ: AMGN) price target raised to $79.00.

Analyst, Christopher Raymond, said, "Raising our ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login